News
GRRMY
7.17
NaN%
--
Weekly Report: what happened at GRRMY last week (0908-0912)?
Weekly Report · 09/15 10:11
Weekly Report: what happened at GRRMY last week (0901-0905)?
Weekly Report · 09/08 10:13
Weekly Report: what happened at GRRMY last week (0825-0829)?
Weekly Report · 09/01 10:10
Weekly Report: what happened at GRRMY last week (0818-0822)?
Weekly Report · 08/25 10:16
Weekly Report: what happened at GRRMY last week (0811-0815)?
Weekly Report · 08/18 10:11
Artisan Global Discovery Fund Q2 2025 Commentary
Seeking Alpha · 08/14 02:15
Weekly Report: what happened at GRRMY last week (0804-0808)?
Weekly Report · 08/11 10:15
Weekly Report: what happened at GRRMY last week (0728-0801)?
Weekly Report · 08/04 10:17
Weekly Report: what happened at GRRMY last week (0721-0725)?
Weekly Report · 07/28 10:17
Oakmark International Small Cap Strategy Q2 2025 Commentary
Seeking Alpha · 07/23 03:50
Weekly Report: what happened at GRRMY last week (0714-0718)?
Weekly Report · 07/21 10:11
Oakmark International Small Cap Fund Q2 2025 Commentary
Seeking Alpha · 07/21 08:07
Weekly Report: what happened at GRRMY last week (0707-0711)?
Weekly Report · 07/14 10:16
ClearBridge Global Value Improvers Strategy Q2 2025 Commentary
Seeking Alpha · 07/10 20:33
ClearBridge International Value Strategy Q2 2025 Commentary
Seeking Alpha · 07/09 12:10
Weekly Report: what happened at GRRMY last week (0630-0704)?
Weekly Report · 07/07 10:12
Weekly Report: what happened at GRRMY last week (0623-0627)?
Weekly Report · 06/30 10:15
Weekly Report: what happened at GRRMY last week (0616-0620)?
Weekly Report · 06/23 10:12
Weekly Report: what happened at GRRMY last week (0609-0613)?
Weekly Report · 06/16 10:15
Weekly Report: what happened at GRRMY last week (0602-0606)?
Weekly Report · 06/09 10:16
More
Webull provides a variety of real-time GRRMY stock news. You can receive the latest news about Gerresheimer through multiple platforms. This information may help you make smarter investment decisions.
About GRRMY
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.